Observational studyRadiology. Imaging cancer2021
Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma.
Open access · diamondAbstract readObservational Study
In one paragraph
Observational study in Radiology. Imaging cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 54 citations in OpenAlex.
- International Myeloma Working Group Recommendations for the Diagnosis and Management of Solitary Plasmacytomas.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026Guideline
- ESR Essentials: bone marrow MRI in oncology-practice recommendations by the European Society of Musculoskeletal Radiology.European radiology · 2026Guideline
- Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.Blood · 2025Trial
- [Imaging in monoclonal plasma cell disorders : Multiple myeloma, smouldering multiple myeloma and MGUS].Radiologie (Heidelberg, Germany) · 2026Review
- AI-derived whole-body MRI metrics in patients with multiple myeloma reveal unique insights into body composition and outcomes.Blood advances · 2026Observational
- Smoldering multiple myeloma: advances in diagnosis and risk stratification, and evolving therapeutic strategies.International journal of hematology · 2026Review
- Prospective Pilot Study ofMolecular imaging and biology · 2026Article
- Why We Do Not Recommend That People With High-Risk Smoldering Myeloma Receive Treatment.American journal of hematology · 2026Article
- Fifteen years of use of functional imaging in multiple myeloma: where we started and where we are going.Blood advances · 2025Review
- Bone disease burden does not impact overall survival in newly diagnosed patients with multiple myeloma - a single center, retrospective imaging analysis on 119 patients.Journal of bone oncology · 2025Article
- Qualitative and Quantitative Inter-Observer Agreement of Multiparametric Whole-Body MRI in Staging and Follow-Up of Myeloma Patients.Diagnostics (Basel, Switzerland) · 2025Article
- Simultaneous whole-body multi-parametric 2-[Leukemia · 2025Article
- Contextualizing results of randomized trials in smoldering myeloma.The oncologist · 2025Article
- Whole body MRI by MY-RADS for imaging response assessment in multiple myeloma.Blood cancer journal · 2025Observational
- Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroup.The Lancet regional health. Western Pacific · 2025Review
- Diagnostic Innovations: Advances in imaging techniques for diagnosis and follow-up of multiple myeloma.Journal of bone oncology · 2025Review
- Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice.Journal of clinical medicine · 2025Article
- How to Identify and Manage High-Risk Smoldering Multiple Myeloma.Current oncology reports · 2024Review
- Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.Skeletal radiology · 2024Review
- National myeloma patient survey shows continuing inappropriate imaging and geographical inequalities.The British journal of radiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 4 institutions in 2 countries.
Christina MessiouFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).ORCID 0000-0002-0557-9379
Nuria PortaFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).ORCID 0000-0003-2458-2167
Bhupinder SharmaFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Daniel LevineFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Dow-Mu KohFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Kevin BoydFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Charlotte PawlynFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Angela RiddellFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Katherine DowneyFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
James CroftFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Veronica MorganFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Simon SternFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Betty CheungFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).ORCID 0000-0003-1050-9487
Charalampia KyriakouFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Pawel KaczmarekFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Jessica WinfieldFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).ORCID 0000-0001-6069-5252
Matthew BlackledgeFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Wim J G OyenFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).ORCID 0000-0001-8235-7078
Martin F KaiserFrom the Royal Marsden Hospital Foundation NHS Trust, Fulham Rd, London SW3 6JJ, England (C.M., B.S., D.L., D.M.K., K.B., C.P., A.R., K.D., J.C., V.M., S.S., J.W., W.J.G.O., M.F.K.); The Institute of Cancer Research, London, England (C.M., N.P., D.M.K., C.P., J.W., M.B., W.J.G.O., M.F.K.); Epsom and St Helier University Hospitals NHS Trust, Epsom, England (S.S.); Croydon University Hospital, Croydon, England (B.C.); University College London Hospital NHS Foundation Trust, London, England (C.K.); and Surrey and Sussex Healthcare NHS Trust, Redhill, England (P.K.).
Royal Marsden NHS Foundation Trust · GBInstitute of Ophthalmology · MXCroydon University Hospital · GBUniversity College London Hospitals NHS Foundation Trust · GB
Funding
Cancer Research UK 25351Cancer Research UK 29957Cancer Research UK C1491/A25351Department of Health C1060/A10334Department of Health C1060/A16464
Abstract
Purpose To compare disease detection of myeloma using contemporary whole-body (WB) MRI and fluorine 18 (
Indexed as
Hematopoietic Stem Cell TransplantationMultiple MyelomaFluorodeoxyglucose F18HumansMagnetic Resonance ImagingMaleMiddle AgedPositron Emission Tomography Computed TomographyProspective StudiesTransplantation, AutologousFluorodeoxyglucose F18Bone MarrowHematologic DiseasesMR-ImagingOncologySkeletal-AppendicularSkeletal-Axial
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.